‘Osteo’ formulations of modified-release paracetamol should be restricted or even banned because of their disproportionate role in overdose harms, toxicologists say. The modified release (665mg) formulations of paracetamol marketed for arthritis pain are difficult to manage in overdose and associated with higher average doses of paracetamol in overdose, according to articles published in the MJA. ...
Overdose harms of ‘osteo’ paracetamol show need for restrictions
By Michael Woodhead
3 Sep 2019